Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-105258
Filing Date
2025-08-07
Accepted
2025-08-07 17:30:22
Documents
1
Period of Report
2025-07-31

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3225
  Complete submission text file 0000950170-25-105258.txt   4662
Mailing Address 730 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 730 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 781-419-1400
Syndax Pharmaceuticals Inc (Issuer) CIK: 0001395937 (see all company filings)

EIN.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 227 WASHINGTON STREET SUITE 200 CONSHOHOCKEN PA 19428
Business Address
Goldan Keith A. (Reporting) CIK: 0001495411 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37708 | Film No.: 251195503